147 related articles for article (PubMed ID: 38369298)
1. Advancements in the diagnosis, prognosis, and treatment of retinoblastoma.
Rajput S; Malviya R; Uniyal P
Can J Ophthalmol; 2024 Feb; ():. PubMed ID: 38369298
[TBL] [Abstract][Full Text] [Related]
2. miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses.
Doghish AS; Moustafa HAM; Elballal MS; Sarhan OM; Darwish SF; Elkalla WS; Mohammed OA; Atta AM; Abdelmaksoud NM; El-Mahdy HA; Ismail A; Abdel Mageed SS; Elrebehy MA; Abdelfatah AM; Abulsoud AI
Pathol Res Pract; 2023 Jul; 247():154537. PubMed ID: 37216745
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma: Review and new insights.
Cruz-Gálvez CC; Ordaz-Favila JC; Villar-Calvo VM; Cancino-Marentes ME; Bosch-Canto V
Front Oncol; 2022; 12():963780. PubMed ID: 36408154
[TBL] [Abstract][Full Text] [Related]
4. Review: New horizons in retinoblastoma treatment: an updated review article.
Azimi F; Mirshahi R; Naseripour M
Mol Vis; 2022; 28():130-146. PubMed ID: 36034735
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of circular RNA hsa_circ_0001649 indicates poor prognosis for retinoblastoma and regulates cell proliferation and apoptosis via AKT/mTOR signaling pathway.
Xing L; Zhang L; Feng Y; Cui Z; Ding L
Biomed Pharmacother; 2018 Sep; 105():326-333. PubMed ID: 29864621
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the RB1 gene in Pakistani patients with retinoblastoma using direct sequencing analysis.
Kalsoom S; Wasim M; Afzal S; Shahzad MS; Ramzan S; Awan AR; Anjum AA; Ramzan K
Mol Vis; 2015; 21():1085-92. PubMed ID: 26396485
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma.
Shen F; Mo MH; Chen L; An S; Tan X; Fu Y; Rezaei K; Wang Z; Zhang L; Fu SW
J Cancer; 2014; 5(9):804-12. PubMed ID: 25520758
[TBL] [Abstract][Full Text] [Related]
9. Etiology including epigenetic defects of retinoblastoma.
Zhou L; Tong Y; Ho BM; Li J; Chan HYE; Zhang T; Du L; He JN; Chen LJ; Tham CC; Yam JC; Pang CP; Chu WK
Asia Pac J Ophthalmol (Phila); 2024; 13(3):100072. PubMed ID: 38789041
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.
Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R
Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472
[TBL] [Abstract][Full Text] [Related]
11. Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy.
Venkatesan N; Deepa PR; Khetan V; Krishnakumar S
Bioinform Biol Insights; 2015; 9():89-101. PubMed ID: 25983556
[TBL] [Abstract][Full Text] [Related]
12. Correlation between Family
Zhang Y; Wang Y; Huang D; Ma J; Zhang W; Gu H; Zhou Y; Yi Y; Zhang P
Dis Markers; 2021; 2021():9981028. PubMed ID: 34336010
[TBL] [Abstract][Full Text] [Related]
13. Expression profiles and prognostic value of miRNAs in retinoblastoma.
Delsin LEA; Salomao KB; Pezuk JA; Brassesco MS
J Cancer Res Clin Oncol; 2019 Jan; 145(1):1-10. PubMed ID: 30350021
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-based delivery systems as emerging therapy in retinoblastoma: recent advances, challenges and prospects.
Onugwu AL; Ugorji OL; Ufondu CA; Ihim SA; Echezona AC; Nwagwu CS; Onugwu SO; Uzondu SW; Agbo CP; Ogbonna JD; Attama AA
Nanoscale Adv; 2023 Sep; 5(18):4628-4648. PubMed ID: 37705787
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive, sensitive and economical approach for the detection of mutations in the RB1 gene in retinoblastoma.
Parsam VL; Kannabiran C; Honavar S; Vemuganti GK; Ali MJ
J Genet; 2009 Dec; 88(4):517-27. PubMed ID: 20090211
[TBL] [Abstract][Full Text] [Related]
16. RB1 gene mutations in Argentine retinoblastoma patients. Implications for genetic counseling.
Parma D; Ferrer M; Luce L; Giliberto F; Szijan I
PLoS One; 2017; 12(12):e0189736. PubMed ID: 29261756
[TBL] [Abstract][Full Text] [Related]
17. Serum exosomal miRNA as biomarkers for Retinoblastoma.
Ravishankar H; Mangani AS; Phoebe Moses GL; Mani SP; Parameswaran S; Khetan V; Ganesan S; Krishnakumar S
Exp Eye Res; 2020 Oct; 199():108184. PubMed ID: 32795526
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA LINC00202 Promotes Tumor Progression by Sponging miR-3619-5p in Retinoblastoma.
Yan G; Su Y; Ma Z; Yu L; Chen N
Cell Struct Funct; 2019; 44(1):51-60. PubMed ID: 30905893
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of multiple bioinformatics studies to identify microRNA-target gene-transcription factor regulatory networks in retinoblastoma.
Wen Y; Zhu M; Zhang X; Xiao H; Wei Y; Zhao P
Transl Cancer Res; 2022 Jul; 11(7):2225-2237. PubMed ID: 35966326
[TBL] [Abstract][Full Text] [Related]
20. Impact of RARα and miR-138 on retinoblastoma etoposide resistance.
Busch M; Miroschnikov N; Dankert JT; Wiesehöfer M; Metz K; Stephan H; Dünker N
Tumour Biol; 2021; 43(1):11-26. PubMed ID: 33935126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]